The world has faced unprecedented challenges due to the COVID-19 pandemic, but it has also opened up enormous opportunities in certain sectors. One such sector is the pharmaceutical industry. India, renowned as the ‘Pharmacy of the World’, has made significant strides during this period, showcasing its potential to become a global leader in the pharmaceutical industry. This, in turn, has opened a promising horizon for Bachelor of Pharmacy (BPharma) graduates in the country.
India’s Rise as a Vaccine Exporting Major
India has always been a leading exporter of generic drugs, but the COVID-19 pandemic catapulted the country into a new limelight – as a vaccine manufacturing powerhouse. The Serum Institute of India, the world’s largest vaccine manufacturer, produced a substantial quantity of the AstraZeneca-Oxford vaccine, marketed as Covishield in India. Bharat Biotech developed Covaxin, an indigenous COVID-19 vaccine, further augmenting India’s reputation in vaccine production. This critical role in the global fight against COVID-19 has paved the way for an increased demand for skilled BPharma graduates.
Also read: Polio vaccine in India: Why did it take so long?
The Success of Hydroxychloroquine (HCQ)
India also demonstrated its prowess in the production of essential drugs during the pandemic. The country became the largest supplier of Hydroxychloroquine (HCQ), an anti-malarial drug that found use in managing COVID-19 symptoms. This success story of HCQ once again underlined the capabilities of India’s pharmaceutical sector and its potential for growth and innovation.
PM Modi’s Push for Homemade Drugs and APIs
Prime Minister Narendra Modi’s push for homemade drugs and active pharmaceutical ingredients (APIs) further bolsters the pharmaceutical sector. The government’s focus on self-reliance, or ‘Atmanirbhar Bharat’, has led to the launch of various schemes to encourage domestic production of APIs and key starting materials (KSMs). This initiative reduces India’s dependence on imports, especially from China, and opens up vast opportunities for innovation and employment in the sector.
Also read: India is all set to fight the menace of cervical cancer with its own indigenous vaccine
India’s Journey to Becoming a Medical Superpower
The stage is set for India to become a medical superpower in the next 5-10 years. The government’s commitment to healthcare, the growth of pharmaceutical companies, the push for research and development, and a robust supply chain are all converging to make this vision a reality.
This growth trajectory creates an opportune environment for BPharma graduates. With increased investment in pharmaceutical research and manufacturing, there will be a surge in demand for skilled professionals who can contribute to drug development, quality control, regulatory affairs, clinical trials, and marketing. BPharma graduates, with their technical knowledge and practical skills, will be at the forefront of this surge, leading and shaping the future of healthcare in India.
Also read: Life comes full circle for the Lancet as it praises Indian vaccines for saving millions of lives
The golden era for BPharma grads in India is indeed around the corner. As India continues to solidify its position as a global pharmaceutical hub, these professionals will be the backbone of the industry. Their knowledge, skills, and innovative thinking will be instrumental in harnessing the vast opportunities that the post-pandemic world presents, making them the gold-diggers in the pharmaceutical rush of the new era.
Support TFI:
Support us to strengthen the ‘Right’ ideology of cultural nationalism by purchasing the best quality garments from TFI-STORE.COM
